id: https://openalex.org/W3119345685
doi: https://doi.org/10.1056/nejmoa2034201
title: "Interim Results of a Phase 1\u20132a Trial of Ad26.COV2.S Covid-19 Vaccine"
publication_date: '2021-01-13'
publication_year: 2021
cited_by_count: 1136
citation_percentile: 0.999959
pagerank: 2.62610927730286e-06
authorships:
- author_id: https://openalex.org/A5034781292
  display_name: Jerald Sadoff
  orcid: https://orcid.org/0000-0002-4839-3013
  author_position: first
  institutions:
  - id: https://openalex.org/I1316535847
    display_name: Beth Israel Deaconess Medical Center
    ror: https://ror.org/04drvxt59
    country_code: US
    type: healthcare
  - id: https://openalex.org/I137982388
    display_name: Janssen (Belgium)
    ror: https://ror.org/04yzcpd71
    country_code: BE
    type: company
  - id: https://openalex.org/I4210154236
    display_name: Janssen (Netherlands)
    ror: https://ror.org/04cxegr21
    country_code: NL
    type: company
  is_corresponding: false
  raw_affiliation_strings:
  - From Janssen Vaccines and Prevention, Leiden, the Netherlands (J. Sadoff, M.L.G.,
    G. Shukarev, A.M.G., J. Stoop, S.T., E.C., G. Scheper, J. Hendriks, M.D., J.V.H.,
    H.S.); Janssen Research and Development, Beerse (D.H., C.T., F.S.), Janssen Clinical
    Pharmacology Unit, Merksem (W.V.D.), the Center for Vaccinology, Ghent University,
    Gent (I.L.-R.), SGS Life Sciences (P.-J.B.) and the Center for the Evaluation
    of Vaccination, University of Antwerp (P.V.D.), Antwerp, and the Center for Clinical
    Pharmacology, University Hospitals Leuven, Leuven (J. de Hoon) - all in Belgium;
    Optimal Research, Melbourne, FL (M.K.); the Alliance for Multispecialty Research,
    Knoxville, TN (W.S.); the Center for Virology and Vaccine Research, Beth Israel
    Deaconess Medical Center, Boston (K.E.S., D.H.B.); and the Vaccine and Infectious
    Disease Division, Fred Hutchinson Cancer Research Center, Seattle (S.C.D.R., K.W.C.,
    M.J.M.).
- author_id: https://openalex.org/A5113844243
  display_name: Mathieu Le Gars
  orcid: null
  author_position: middle
  institutions:
  - id: https://openalex.org/I1316535847
    display_name: Beth Israel Deaconess Medical Center
    ror: https://ror.org/04drvxt59
    country_code: US
    type: healthcare
  - id: https://openalex.org/I137982388
    display_name: Janssen (Belgium)
    ror: https://ror.org/04yzcpd71
    country_code: BE
    type: company
  - id: https://openalex.org/I4210154236
    display_name: Janssen (Netherlands)
    ror: https://ror.org/04cxegr21
    country_code: NL
    type: company
  is_corresponding: false
  raw_affiliation_strings:
  - From Janssen Vaccines and Prevention, Leiden, the Netherlands (J. Sadoff, M.L.G.,
    G. Shukarev, A.M.G., J. Stoop, S.T., E.C., G. Scheper, J. Hendriks, M.D., J.V.H.,
    H.S.); Janssen Research and Development, Beerse (D.H., C.T., F.S.), Janssen Clinical
    Pharmacology Unit, Merksem (W.V.D.), the Center for Vaccinology, Ghent University,
    Gent (I.L.-R.), SGS Life Sciences (P.-J.B.) and the Center for the Evaluation
    of Vaccination, University of Antwerp (P.V.D.), Antwerp, and the Center for Clinical
    Pharmacology, University Hospitals Leuven, Leuven (J. de Hoon) - all in Belgium;
    Optimal Research, Melbourne, FL (M.K.); the Alliance for Multispecialty Research,
    Knoxville, TN (W.S.); the Center for Virology and Vaccine Research, Beth Israel
    Deaconess Medical Center, Boston (K.E.S., D.H.B.); and the Vaccine and Infectious
    Disease Division, Fred Hutchinson Cancer Research Center, Seattle (S.C.D.R., K.W.C.,
    M.J.M.).
- author_id: https://openalex.org/A5014091521
  display_name: Georgi Shukarev
  orcid: https://orcid.org/0000-0001-5154-7047
  author_position: middle
  institutions:
  - id: https://openalex.org/I1316535847
    display_name: Beth Israel Deaconess Medical Center
    ror: https://ror.org/04drvxt59
    country_code: US
    type: healthcare
  - id: https://openalex.org/I137982388
    display_name: Janssen (Belgium)
    ror: https://ror.org/04yzcpd71
    country_code: BE
    type: company
  - id: https://openalex.org/I4210154236
    display_name: Janssen (Netherlands)
    ror: https://ror.org/04cxegr21
    country_code: NL
    type: company
  is_corresponding: false
  raw_affiliation_strings:
  - From Janssen Vaccines and Prevention, Leiden, the Netherlands (J. Sadoff, M.L.G.,
    G. Shukarev, A.M.G., J. Stoop, S.T., E.C., G. Scheper, J. Hendriks, M.D., J.V.H.,
    H.S.); Janssen Research and Development, Beerse (D.H., C.T., F.S.), Janssen Clinical
    Pharmacology Unit, Merksem (W.V.D.), the Center for Vaccinology, Ghent University,
    Gent (I.L.-R.), SGS Life Sciences (P.-J.B.) and the Center for the Evaluation
    of Vaccination, University of Antwerp (P.V.D.), Antwerp, and the Center for Clinical
    Pharmacology, University Hospitals Leuven, Leuven (J. de Hoon) - all in Belgium;
    Optimal Research, Melbourne, FL (M.K.); the Alliance for Multispecialty Research,
    Knoxville, TN (W.S.); the Center for Virology and Vaccine Research, Beth Israel
    Deaconess Medical Center, Boston (K.E.S., D.H.B.); and the Vaccine and Infectious
    Disease Division, Fred Hutchinson Cancer Research Center, Seattle (S.C.D.R., K.W.C.,
    M.J.M.).
- author_id: https://openalex.org/A5017072849
  display_name: Dirk Heerwegh
  orcid: null
  author_position: middle
  institutions:
  - id: https://openalex.org/I1316535847
    display_name: Beth Israel Deaconess Medical Center
    ror: https://ror.org/04drvxt59
    country_code: US
    type: healthcare
  - id: https://openalex.org/I137982388
    display_name: Janssen (Belgium)
    ror: https://ror.org/04yzcpd71
    country_code: BE
    type: company
  - id: https://openalex.org/I4210154236
    display_name: Janssen (Netherlands)
    ror: https://ror.org/04cxegr21
    country_code: NL
    type: company
  is_corresponding: false
  raw_affiliation_strings:
  - From Janssen Vaccines and Prevention, Leiden, the Netherlands (J. Sadoff, M.L.G.,
    G. Shukarev, A.M.G., J. Stoop, S.T., E.C., G. Scheper, J. Hendriks, M.D., J.V.H.,
    H.S.); Janssen Research and Development, Beerse (D.H., C.T., F.S.), Janssen Clinical
    Pharmacology Unit, Merksem (W.V.D.), the Center for Vaccinology, Ghent University,
    Gent (I.L.-R.), SGS Life Sciences (P.-J.B.) and the Center for the Evaluation
    of Vaccination, University of Antwerp (P.V.D.), Antwerp, and the Center for Clinical
    Pharmacology, University Hospitals Leuven, Leuven (J. de Hoon) - all in Belgium;
    Optimal Research, Melbourne, FL (M.K.); the Alliance for Multispecialty Research,
    Knoxville, TN (W.S.); the Center for Virology and Vaccine Research, Beth Israel
    Deaconess Medical Center, Boston (K.E.S., D.H.B.); and the Vaccine and Infectious
    Disease Division, Fred Hutchinson Cancer Research Center, Seattle (S.C.D.R., K.W.C.,
    M.J.M.).
- author_id: https://openalex.org/A5080052175
  display_name: Carla Truyers
  orcid: null
  author_position: middle
  institutions:
  - id: https://openalex.org/I1316535847
    display_name: Beth Israel Deaconess Medical Center
    ror: https://ror.org/04drvxt59
    country_code: US
    type: healthcare
  - id: https://openalex.org/I137982388
    display_name: Janssen (Belgium)
    ror: https://ror.org/04yzcpd71
    country_code: BE
    type: company
  - id: https://openalex.org/I4210154236
    display_name: Janssen (Netherlands)
    ror: https://ror.org/04cxegr21
    country_code: NL
    type: company
  is_corresponding: false
  raw_affiliation_strings:
  - From Janssen Vaccines and Prevention, Leiden, the Netherlands (J. Sadoff, M.L.G.,
    G. Shukarev, A.M.G., J. Stoop, S.T., E.C., G. Scheper, J. Hendriks, M.D., J.V.H.,
    H.S.); Janssen Research and Development, Beerse (D.H., C.T., F.S.), Janssen Clinical
    Pharmacology Unit, Merksem (W.V.D.), the Center for Vaccinology, Ghent University,
    Gent (I.L.-R.), SGS Life Sciences (P.-J.B.) and the Center for the Evaluation
    of Vaccination, University of Antwerp (P.V.D.), Antwerp, and the Center for Clinical
    Pharmacology, University Hospitals Leuven, Leuven (J. de Hoon) - all in Belgium;
    Optimal Research, Melbourne, FL (M.K.); the Alliance for Multispecialty Research,
    Knoxville, TN (W.S.); the Center for Virology and Vaccine Research, Beth Israel
    Deaconess Medical Center, Boston (K.E.S., D.H.B.); and the Vaccine and Infectious
    Disease Division, Fred Hutchinson Cancer Research Center, Seattle (S.C.D.R., K.W.C.,
    M.J.M.).
- author_id: https://openalex.org/A5047537522
  display_name: Anne Marit de Groot
  orcid: https://orcid.org/0000-0002-4782-3392
  author_position: middle
  institutions:
  - id: https://openalex.org/I1316535847
    display_name: Beth Israel Deaconess Medical Center
    ror: https://ror.org/04drvxt59
    country_code: US
    type: healthcare
  - id: https://openalex.org/I137982388
    display_name: Janssen (Belgium)
    ror: https://ror.org/04yzcpd71
    country_code: BE
    type: company
  - id: https://openalex.org/I4210154236
    display_name: Janssen (Netherlands)
    ror: https://ror.org/04cxegr21
    country_code: NL
    type: company
  is_corresponding: false
  raw_affiliation_strings:
  - From Janssen Vaccines and Prevention, Leiden, the Netherlands (J. Sadoff, M.L.G.,
    G. Shukarev, A.M.G., J. Stoop, S.T., E.C., G. Scheper, J. Hendriks, M.D., J.V.H.,
    H.S.); Janssen Research and Development, Beerse (D.H., C.T., F.S.), Janssen Clinical
    Pharmacology Unit, Merksem (W.V.D.), the Center for Vaccinology, Ghent University,
    Gent (I.L.-R.), SGS Life Sciences (P.-J.B.) and the Center for the Evaluation
    of Vaccination, University of Antwerp (P.V.D.), Antwerp, and the Center for Clinical
    Pharmacology, University Hospitals Leuven, Leuven (J. de Hoon) - all in Belgium;
    Optimal Research, Melbourne, FL (M.K.); the Alliance for Multispecialty Research,
    Knoxville, TN (W.S.); the Center for Virology and Vaccine Research, Beth Israel
    Deaconess Medical Center, Boston (K.E.S., D.H.B.); and the Vaccine and Infectious
    Disease Division, Fred Hutchinson Cancer Research Center, Seattle (S.C.D.R., K.W.C.,
    M.J.M.).
- author_id: https://openalex.org/A5020489800
  display_name: Jeroen N. Stoop
  orcid: null
  author_position: middle
  institutions:
  - id: https://openalex.org/I1316535847
    display_name: Beth Israel Deaconess Medical Center
    ror: https://ror.org/04drvxt59
    country_code: US
    type: healthcare
  - id: https://openalex.org/I137982388
    display_name: Janssen (Belgium)
    ror: https://ror.org/04yzcpd71
    country_code: BE
    type: company
  - id: https://openalex.org/I4210154236
    display_name: Janssen (Netherlands)
    ror: https://ror.org/04cxegr21
    country_code: NL
    type: company
  is_corresponding: false
  raw_affiliation_strings:
  - From Janssen Vaccines and Prevention, Leiden, the Netherlands (J. Sadoff, M.L.G.,
    G. Shukarev, A.M.G., J. Stoop, S.T., E.C., G. Scheper, J. Hendriks, M.D., J.V.H.,
    H.S.); Janssen Research and Development, Beerse (D.H., C.T., F.S.), Janssen Clinical
    Pharmacology Unit, Merksem (W.V.D.), the Center for Vaccinology, Ghent University,
    Gent (I.L.-R.), SGS Life Sciences (P.-J.B.) and the Center for the Evaluation
    of Vaccination, University of Antwerp (P.V.D.), Antwerp, and the Center for Clinical
    Pharmacology, University Hospitals Leuven, Leuven (J. de Hoon) - all in Belgium;
    Optimal Research, Melbourne, FL (M.K.); the Alliance for Multispecialty Research,
    Knoxville, TN (W.S.); the Center for Virology and Vaccine Research, Beth Israel
    Deaconess Medical Center, Boston (K.E.S., D.H.B.); and the Vaccine and Infectious
    Disease Division, Fred Hutchinson Cancer Research Center, Seattle (S.C.D.R., K.W.C.,
    M.J.M.).
- author_id: https://openalex.org/A5086192025
  display_name: Sarah M. Tete
  orcid: null
  author_position: middle
  institutions:
  - id: https://openalex.org/I1316535847
    display_name: Beth Israel Deaconess Medical Center
    ror: https://ror.org/04drvxt59
    country_code: US
    type: healthcare
  - id: https://openalex.org/I137982388
    display_name: Janssen (Belgium)
    ror: https://ror.org/04yzcpd71
    country_code: BE
    type: company
  - id: https://openalex.org/I4210154236
    display_name: Janssen (Netherlands)
    ror: https://ror.org/04cxegr21
    country_code: NL
    type: company
  is_corresponding: false
  raw_affiliation_strings:
  - From Janssen Vaccines and Prevention, Leiden, the Netherlands (J. Sadoff, M.L.G.,
    G. Shukarev, A.M.G., J. Stoop, S.T., E.C., G. Scheper, J. Hendriks, M.D., J.V.H.,
    H.S.); Janssen Research and Development, Beerse (D.H., C.T., F.S.), Janssen Clinical
    Pharmacology Unit, Merksem (W.V.D.), the Center for Vaccinology, Ghent University,
    Gent (I.L.-R.), SGS Life Sciences (P.-J.B.) and the Center for the Evaluation
    of Vaccination, University of Antwerp (P.V.D.), Antwerp, and the Center for Clinical
    Pharmacology, University Hospitals Leuven, Leuven (J. de Hoon) - all in Belgium;
    Optimal Research, Melbourne, FL (M.K.); the Alliance for Multispecialty Research,
    Knoxville, TN (W.S.); the Center for Virology and Vaccine Research, Beth Israel
    Deaconess Medical Center, Boston (K.E.S., D.H.B.); and the Vaccine and Infectious
    Disease Division, Fred Hutchinson Cancer Research Center, Seattle (S.C.D.R., K.W.C.,
    M.J.M.).
- author_id: https://openalex.org/A5025047911
  display_name: Wim Van Damme
  orcid: https://orcid.org/0000-0002-6344-3007
  author_position: middle
  institutions:
  - id: https://openalex.org/I1316535847
    display_name: Beth Israel Deaconess Medical Center
    ror: https://ror.org/04drvxt59
    country_code: US
    type: healthcare
  - id: https://openalex.org/I137982388
    display_name: Janssen (Belgium)
    ror: https://ror.org/04yzcpd71
    country_code: BE
    type: company
  - id: https://openalex.org/I4210154236
    display_name: Janssen (Netherlands)
    ror: https://ror.org/04cxegr21
    country_code: NL
    type: company
  is_corresponding: false
  raw_affiliation_strings:
  - From Janssen Vaccines and Prevention, Leiden, the Netherlands (J. Sadoff, M.L.G.,
    G. Shukarev, A.M.G., J. Stoop, S.T., E.C., G. Scheper, J. Hendriks, M.D., J.V.H.,
    H.S.); Janssen Research and Development, Beerse (D.H., C.T., F.S.), Janssen Clinical
    Pharmacology Unit, Merksem (W.V.D.), the Center for Vaccinology, Ghent University,
    Gent (I.L.-R.), SGS Life Sciences (P.-J.B.) and the Center for the Evaluation
    of Vaccination, University of Antwerp (P.V.D.), Antwerp, and the Center for Clinical
    Pharmacology, University Hospitals Leuven, Leuven (J. de Hoon) - all in Belgium;
    Optimal Research, Melbourne, FL (M.K.); the Alliance for Multispecialty Research,
    Knoxville, TN (W.S.); the Center for Virology and Vaccine Research, Beth Israel
    Deaconess Medical Center, Boston (K.E.S., D.H.B.); and the Vaccine and Infectious
    Disease Division, Fred Hutchinson Cancer Research Center, Seattle (S.C.D.R., K.W.C.,
    M.J.M.).
- author_id: https://openalex.org/A5028880152
  display_name: "Isabel Leroux\u2010Roels"
  orcid: https://orcid.org/0000-0002-5084-4696
  author_position: middle
  institutions:
  - id: https://openalex.org/I137982388
    display_name: Janssen (Belgium)
    ror: https://ror.org/04yzcpd71
    country_code: BE
    type: company
  - id: https://openalex.org/I4210154236
    display_name: Janssen (Netherlands)
    ror: https://ror.org/04cxegr21
    country_code: NL
    type: company
  - id: https://openalex.org/I1316535847
    display_name: Beth Israel Deaconess Medical Center
    ror: https://ror.org/04drvxt59
    country_code: US
    type: healthcare
  is_corresponding: false
  raw_affiliation_strings:
  - From Janssen Vaccines and Prevention, Leiden, the Netherlands (J. Sadoff, M.L.G.,
    G. Shukarev, A.M.G., J. Stoop, S.T., E.C., G. Scheper, J. Hendriks, M.D., J.V.H.,
    H.S.); Janssen Research and Development, Beerse (D.H., C.T., F.S.), Janssen Clinical
    Pharmacology Unit, Merksem (W.V.D.), the Center for Vaccinology, Ghent University,
    Gent (I.L.-R.), SGS Life Sciences (P.-J.B.) and the Center for the Evaluation
    of Vaccination, University of Antwerp (P.V.D.), Antwerp, and the Center for Clinical
    Pharmacology, University Hospitals Leuven, Leuven (J. de Hoon) - all in Belgium;
    Optimal Research, Melbourne, FL (M.K.); the Alliance for Multispecialty Research,
    Knoxville, TN (W.S.); the Center for Virology and Vaccine Research, Beth Israel
    Deaconess Medical Center, Boston (K.E.S., D.H.B.); and the Vaccine and Infectious
    Disease Division, Fred Hutchinson Cancer Research Center, Seattle (S.C.D.R., K.W.C.,
    M.J.M.).
- author_id: https://openalex.org/A5080874005
  display_name: Pieter-Jan Berghmans
  orcid: null
  author_position: middle
  institutions:
  - id: https://openalex.org/I4210154236
    display_name: Janssen (Netherlands)
    ror: https://ror.org/04cxegr21
    country_code: NL
    type: company
  - id: https://openalex.org/I1316535847
    display_name: Beth Israel Deaconess Medical Center
    ror: https://ror.org/04drvxt59
    country_code: US
    type: healthcare
  - id: https://openalex.org/I137982388
    display_name: Janssen (Belgium)
    ror: https://ror.org/04yzcpd71
    country_code: BE
    type: company
  is_corresponding: false
  raw_affiliation_strings:
  - From Janssen Vaccines and Prevention, Leiden, the Netherlands (J. Sadoff, M.L.G.,
    G. Shukarev, A.M.G., J. Stoop, S.T., E.C., G. Scheper, J. Hendriks, M.D., J.V.H.,
    H.S.); Janssen Research and Development, Beerse (D.H., C.T., F.S.), Janssen Clinical
    Pharmacology Unit, Merksem (W.V.D.), the Center for Vaccinology, Ghent University,
    Gent (I.L.-R.), SGS Life Sciences (P.-J.B.) and the Center for the Evaluation
    of Vaccination, University of Antwerp (P.V.D.), Antwerp, and the Center for Clinical
    Pharmacology, University Hospitals Leuven, Leuven (J. de Hoon) - all in Belgium;
    Optimal Research, Melbourne, FL (M.K.); the Alliance for Multispecialty Research,
    Knoxville, TN (W.S.); the Center for Virology and Vaccine Research, Beth Israel
    Deaconess Medical Center, Boston (K.E.S., D.H.B.); and the Vaccine and Infectious
    Disease Division, Fred Hutchinson Cancer Research Center, Seattle (S.C.D.R., K.W.C.,
    M.J.M.).
- author_id: https://openalex.org/A5112574005
  display_name: Murray Kimmel
  orcid: null
  author_position: middle
  institutions:
  - id: https://openalex.org/I1316535847
    display_name: Beth Israel Deaconess Medical Center
    ror: https://ror.org/04drvxt59
    country_code: US
    type: healthcare
  - id: https://openalex.org/I137982388
    display_name: Janssen (Belgium)
    ror: https://ror.org/04yzcpd71
    country_code: BE
    type: company
  - id: https://openalex.org/I4210154236
    display_name: Janssen (Netherlands)
    ror: https://ror.org/04cxegr21
    country_code: NL
    type: company
  is_corresponding: false
  raw_affiliation_strings:
  - From Janssen Vaccines and Prevention, Leiden, the Netherlands (J. Sadoff, M.L.G.,
    G. Shukarev, A.M.G., J. Stoop, S.T., E.C., G. Scheper, J. Hendriks, M.D., J.V.H.,
    H.S.); Janssen Research and Development, Beerse (D.H., C.T., F.S.), Janssen Clinical
    Pharmacology Unit, Merksem (W.V.D.), the Center for Vaccinology, Ghent University,
    Gent (I.L.-R.), SGS Life Sciences (P.-J.B.) and the Center for the Evaluation
    of Vaccination, University of Antwerp (P.V.D.), Antwerp, and the Center for Clinical
    Pharmacology, University Hospitals Leuven, Leuven (J. de Hoon) - all in Belgium;
    Optimal Research, Melbourne, FL (M.K.); the Alliance for Multispecialty Research,
    Knoxville, TN (W.S.); the Center for Virology and Vaccine Research, Beth Israel
    Deaconess Medical Center, Boston (K.E.S., D.H.B.); and the Vaccine and Infectious
    Disease Division, Fred Hutchinson Cancer Research Center, Seattle (S.C.D.R., K.W.C.,
    M.J.M.).
- author_id: https://openalex.org/A5034878566
  display_name: Pierre Van Damme
  orcid: https://orcid.org/0000-0002-8642-1249
  author_position: middle
  institutions:
  - id: https://openalex.org/I1316535847
    display_name: Beth Israel Deaconess Medical Center
    ror: https://ror.org/04drvxt59
    country_code: US
    type: healthcare
  - id: https://openalex.org/I137982388
    display_name: Janssen (Belgium)
    ror: https://ror.org/04yzcpd71
    country_code: BE
    type: company
  - id: https://openalex.org/I4210154236
    display_name: Janssen (Netherlands)
    ror: https://ror.org/04cxegr21
    country_code: NL
    type: company
  is_corresponding: false
  raw_affiliation_strings:
  - From Janssen Vaccines and Prevention, Leiden, the Netherlands (J. Sadoff, M.L.G.,
    G. Shukarev, A.M.G., J. Stoop, S.T., E.C., G. Scheper, J. Hendriks, M.D., J.V.H.,
    H.S.); Janssen Research and Development, Beerse (D.H., C.T., F.S.), Janssen Clinical
    Pharmacology Unit, Merksem (W.V.D.), the Center for Vaccinology, Ghent University,
    Gent (I.L.-R.), SGS Life Sciences (P.-J.B.) and the Center for the Evaluation
    of Vaccination, University of Antwerp (P.V.D.), Antwerp, and the Center for Clinical
    Pharmacology, University Hospitals Leuven, Leuven (J. de Hoon) - all in Belgium;
    Optimal Research, Melbourne, FL (M.K.); the Alliance for Multispecialty Research,
    Knoxville, TN (W.S.); the Center for Virology and Vaccine Research, Beth Israel
    Deaconess Medical Center, Boston (K.E.S., D.H.B.); and the Vaccine and Infectious
    Disease Division, Fred Hutchinson Cancer Research Center, Seattle (S.C.D.R., K.W.C.,
    M.J.M.).
- author_id: https://openalex.org/A5079903461
  display_name: Jan de Hoon
  orcid: https://orcid.org/0000-0002-5215-9836
  author_position: middle
  institutions:
  - id: https://openalex.org/I1316535847
    display_name: Beth Israel Deaconess Medical Center
    ror: https://ror.org/04drvxt59
    country_code: US
    type: healthcare
  - id: https://openalex.org/I137982388
    display_name: Janssen (Belgium)
    ror: https://ror.org/04yzcpd71
    country_code: BE
    type: company
  - id: https://openalex.org/I4210154236
    display_name: Janssen (Netherlands)
    ror: https://ror.org/04cxegr21
    country_code: NL
    type: company
  is_corresponding: false
  raw_affiliation_strings:
  - From Janssen Vaccines and Prevention, Leiden, the Netherlands (J. Sadoff, M.L.G.,
    G. Shukarev, A.M.G., J. Stoop, S.T., E.C., G. Scheper, J. Hendriks, M.D., J.V.H.,
    H.S.); Janssen Research and Development, Beerse (D.H., C.T., F.S.), Janssen Clinical
    Pharmacology Unit, Merksem (W.V.D.), the Center for Vaccinology, Ghent University,
    Gent (I.L.-R.), SGS Life Sciences (P.-J.B.) and the Center for the Evaluation
    of Vaccination, University of Antwerp (P.V.D.), Antwerp, and the Center for Clinical
    Pharmacology, University Hospitals Leuven, Leuven (J. de Hoon) - all in Belgium;
    Optimal Research, Melbourne, FL (M.K.); the Alliance for Multispecialty Research,
    Knoxville, TN (W.S.); the Center for Virology and Vaccine Research, Beth Israel
    Deaconess Medical Center, Boston (K.E.S., D.H.B.); and the Vaccine and Infectious
    Disease Division, Fred Hutchinson Cancer Research Center, Seattle (S.C.D.R., K.W.C.,
    M.J.M.).
- author_id: https://openalex.org/A5109892299
  display_name: William Smith
  orcid: null
  author_position: middle
  institutions:
  - id: https://openalex.org/I1316535847
    display_name: Beth Israel Deaconess Medical Center
    ror: https://ror.org/04drvxt59
    country_code: US
    type: healthcare
  - id: https://openalex.org/I137982388
    display_name: Janssen (Belgium)
    ror: https://ror.org/04yzcpd71
    country_code: BE
    type: company
  - id: https://openalex.org/I4210154236
    display_name: Janssen (Netherlands)
    ror: https://ror.org/04cxegr21
    country_code: NL
    type: company
  is_corresponding: false
  raw_affiliation_strings:
  - From Janssen Vaccines and Prevention, Leiden, the Netherlands (J. Sadoff, M.L.G.,
    G. Shukarev, A.M.G., J. Stoop, S.T., E.C., G. Scheper, J. Hendriks, M.D., J.V.H.,
    H.S.); Janssen Research and Development, Beerse (D.H., C.T., F.S.), Janssen Clinical
    Pharmacology Unit, Merksem (W.V.D.), the Center for Vaccinology, Ghent University,
    Gent (I.L.-R.), SGS Life Sciences (P.-J.B.) and the Center for the Evaluation
    of Vaccination, University of Antwerp (P.V.D.), Antwerp, and the Center for Clinical
    Pharmacology, University Hospitals Leuven, Leuven (J. de Hoon) - all in Belgium;
    Optimal Research, Melbourne, FL (M.K.); the Alliance for Multispecialty Research,
    Knoxville, TN (W.S.); the Center for Virology and Vaccine Research, Beth Israel
    Deaconess Medical Center, Boston (K.E.S., D.H.B.); and the Vaccine and Infectious
    Disease Division, Fred Hutchinson Cancer Research Center, Seattle (S.C.D.R., K.W.C.,
    M.J.M.).
- author_id: https://openalex.org/A5035644016
  display_name: Kathryn E. Stephenson
  orcid: https://orcid.org/0000-0002-3440-4105
  author_position: middle
  institutions:
  - id: https://openalex.org/I1316535847
    display_name: Beth Israel Deaconess Medical Center
    ror: https://ror.org/04drvxt59
    country_code: US
    type: healthcare
  - id: https://openalex.org/I137982388
    display_name: Janssen (Belgium)
    ror: https://ror.org/04yzcpd71
    country_code: BE
    type: company
  - id: https://openalex.org/I4210154236
    display_name: Janssen (Netherlands)
    ror: https://ror.org/04cxegr21
    country_code: NL
    type: company
  is_corresponding: false
  raw_affiliation_strings:
  - From Janssen Vaccines and Prevention, Leiden, the Netherlands (J. Sadoff, M.L.G.,
    G. Shukarev, A.M.G., J. Stoop, S.T., E.C., G. Scheper, J. Hendriks, M.D., J.V.H.,
    H.S.); Janssen Research and Development, Beerse (D.H., C.T., F.S.), Janssen Clinical
    Pharmacology Unit, Merksem (W.V.D.), the Center for Vaccinology, Ghent University,
    Gent (I.L.-R.), SGS Life Sciences (P.-J.B.) and the Center for the Evaluation
    of Vaccination, University of Antwerp (P.V.D.), Antwerp, and the Center for Clinical
    Pharmacology, University Hospitals Leuven, Leuven (J. de Hoon) - all in Belgium;
    Optimal Research, Melbourne, FL (M.K.); the Alliance for Multispecialty Research,
    Knoxville, TN (W.S.); the Center for Virology and Vaccine Research, Beth Israel
    Deaconess Medical Center, Boston (K.E.S., D.H.B.); and the Vaccine and Infectious
    Disease Division, Fred Hutchinson Cancer Research Center, Seattle (S.C.D.R., K.W.C.,
    M.J.M.).
- author_id: https://openalex.org/A5108707946
  display_name: Stephen C. De Rosa
  orcid: https://orcid.org/0009-0007-1360-8727
  author_position: middle
  institutions:
  - id: https://openalex.org/I1316535847
    display_name: Beth Israel Deaconess Medical Center
    ror: https://ror.org/04drvxt59
    country_code: US
    type: healthcare
  - id: https://openalex.org/I137982388
    display_name: Janssen (Belgium)
    ror: https://ror.org/04yzcpd71
    country_code: BE
    type: company
  - id: https://openalex.org/I4210154236
    display_name: Janssen (Netherlands)
    ror: https://ror.org/04cxegr21
    country_code: NL
    type: company
  is_corresponding: false
  raw_affiliation_strings:
  - From Janssen Vaccines and Prevention, Leiden, the Netherlands (J. Sadoff, M.L.G.,
    G. Shukarev, A.M.G., J. Stoop, S.T., E.C., G. Scheper, J. Hendriks, M.D., J.V.H.,
    H.S.); Janssen Research and Development, Beerse (D.H., C.T., F.S.), Janssen Clinical
    Pharmacology Unit, Merksem (W.V.D.), the Center for Vaccinology, Ghent University,
    Gent (I.L.-R.), SGS Life Sciences (P.-J.B.) and the Center for the Evaluation
    of Vaccination, University of Antwerp (P.V.D.), Antwerp, and the Center for Clinical
    Pharmacology, University Hospitals Leuven, Leuven (J. de Hoon) - all in Belgium;
    Optimal Research, Melbourne, FL (M.K.); the Alliance for Multispecialty Research,
    Knoxville, TN (W.S.); the Center for Virology and Vaccine Research, Beth Israel
    Deaconess Medical Center, Boston (K.E.S., D.H.B.); and the Vaccine and Infectious
    Disease Division, Fred Hutchinson Cancer Research Center, Seattle (S.C.D.R., K.W.C.,
    M.J.M.).
- author_id: https://openalex.org/A5013584124
  display_name: Kristen W. Cohen
  orcid: https://orcid.org/0000-0002-8901-9941
  author_position: middle
  institutions:
  - id: https://openalex.org/I1316535847
    display_name: Beth Israel Deaconess Medical Center
    ror: https://ror.org/04drvxt59
    country_code: US
    type: healthcare
  - id: https://openalex.org/I137982388
    display_name: Janssen (Belgium)
    ror: https://ror.org/04yzcpd71
    country_code: BE
    type: company
  - id: https://openalex.org/I4210154236
    display_name: Janssen (Netherlands)
    ror: https://ror.org/04cxegr21
    country_code: NL
    type: company
  is_corresponding: false
  raw_affiliation_strings:
  - From Janssen Vaccines and Prevention, Leiden, the Netherlands (J. Sadoff, M.L.G.,
    G. Shukarev, A.M.G., J. Stoop, S.T., E.C., G. Scheper, J. Hendriks, M.D., J.V.H.,
    H.S.); Janssen Research and Development, Beerse (D.H., C.T., F.S.), Janssen Clinical
    Pharmacology Unit, Merksem (W.V.D.), the Center for Vaccinology, Ghent University,
    Gent (I.L.-R.), SGS Life Sciences (P.-J.B.) and the Center for the Evaluation
    of Vaccination, University of Antwerp (P.V.D.), Antwerp, and the Center for Clinical
    Pharmacology, University Hospitals Leuven, Leuven (J. de Hoon) - all in Belgium;
    Optimal Research, Melbourne, FL (M.K.); the Alliance for Multispecialty Research,
    Knoxville, TN (W.S.); the Center for Virology and Vaccine Research, Beth Israel
    Deaconess Medical Center, Boston (K.E.S., D.H.B.); and the Vaccine and Infectious
    Disease Division, Fred Hutchinson Cancer Research Center, Seattle (S.C.D.R., K.W.C.,
    M.J.M.).
- author_id: https://openalex.org/A5084520588
  display_name: M. Juliana McElrath
  orcid: https://orcid.org/0000-0003-2276-7117
  author_position: middle
  institutions:
  - id: https://openalex.org/I1316535847
    display_name: Beth Israel Deaconess Medical Center
    ror: https://ror.org/04drvxt59
    country_code: US
    type: healthcare
  - id: https://openalex.org/I137982388
    display_name: Janssen (Belgium)
    ror: https://ror.org/04yzcpd71
    country_code: BE
    type: company
  - id: https://openalex.org/I4210154236
    display_name: Janssen (Netherlands)
    ror: https://ror.org/04cxegr21
    country_code: NL
    type: company
  is_corresponding: false
  raw_affiliation_strings:
  - From Janssen Vaccines and Prevention, Leiden, the Netherlands (J. Sadoff, M.L.G.,
    G. Shukarev, A.M.G., J. Stoop, S.T., E.C., G. Scheper, J. Hendriks, M.D., J.V.H.,
    H.S.); Janssen Research and Development, Beerse (D.H., C.T., F.S.), Janssen Clinical
    Pharmacology Unit, Merksem (W.V.D.), the Center for Vaccinology, Ghent University,
    Gent (I.L.-R.), SGS Life Sciences (P.-J.B.) and the Center for the Evaluation
    of Vaccination, University of Antwerp (P.V.D.), Antwerp, and the Center for Clinical
    Pharmacology, University Hospitals Leuven, Leuven (J. de Hoon) - all in Belgium;
    Optimal Research, Melbourne, FL (M.K.); the Alliance for Multispecialty Research,
    Knoxville, TN (W.S.); the Center for Virology and Vaccine Research, Beth Israel
    Deaconess Medical Center, Boston (K.E.S., D.H.B.); and the Vaccine and Infectious
    Disease Division, Fred Hutchinson Cancer Research Center, Seattle (S.C.D.R., K.W.C.,
    M.J.M.).
- author_id: https://openalex.org/A5056300737
  display_name: Emmanuel Cormier
  orcid: null
  author_position: middle
  institutions:
  - id: https://openalex.org/I1316535847
    display_name: Beth Israel Deaconess Medical Center
    ror: https://ror.org/04drvxt59
    country_code: US
    type: healthcare
  - id: https://openalex.org/I137982388
    display_name: Janssen (Belgium)
    ror: https://ror.org/04yzcpd71
    country_code: BE
    type: company
  - id: https://openalex.org/I4210154236
    display_name: Janssen (Netherlands)
    ror: https://ror.org/04cxegr21
    country_code: NL
    type: company
  is_corresponding: false
  raw_affiliation_strings:
  - From Janssen Vaccines and Prevention, Leiden, the Netherlands (J. Sadoff, M.L.G.,
    G. Shukarev, A.M.G., J. Stoop, S.T., E.C., G. Scheper, J. Hendriks, M.D., J.V.H.,
    H.S.); Janssen Research and Development, Beerse (D.H., C.T., F.S.), Janssen Clinical
    Pharmacology Unit, Merksem (W.V.D.), the Center for Vaccinology, Ghent University,
    Gent (I.L.-R.), SGS Life Sciences (P.-J.B.) and the Center for the Evaluation
    of Vaccination, University of Antwerp (P.V.D.), Antwerp, and the Center for Clinical
    Pharmacology, University Hospitals Leuven, Leuven (J. de Hoon) - all in Belgium;
    Optimal Research, Melbourne, FL (M.K.); the Alliance for Multispecialty Research,
    Knoxville, TN (W.S.); the Center for Virology and Vaccine Research, Beth Israel
    Deaconess Medical Center, Boston (K.E.S., D.H.B.); and the Vaccine and Infectious
    Disease Division, Fred Hutchinson Cancer Research Center, Seattle (S.C.D.R., K.W.C.,
    M.J.M.).
- author_id: https://openalex.org/A5022031402
  display_name: Gert C. Scheper
  orcid: https://orcid.org/0000-0003-2316-756X
  author_position: middle
  institutions:
  - id: https://openalex.org/I1316535847
    display_name: Beth Israel Deaconess Medical Center
    ror: https://ror.org/04drvxt59
    country_code: US
    type: healthcare
  - id: https://openalex.org/I137982388
    display_name: Janssen (Belgium)
    ror: https://ror.org/04yzcpd71
    country_code: BE
    type: company
  - id: https://openalex.org/I4210154236
    display_name: Janssen (Netherlands)
    ror: https://ror.org/04cxegr21
    country_code: NL
    type: company
  is_corresponding: false
  raw_affiliation_strings:
  - From Janssen Vaccines and Prevention, Leiden, the Netherlands (J. Sadoff, M.L.G.,
    G. Shukarev, A.M.G., J. Stoop, S.T., E.C., G. Scheper, J. Hendriks, M.D., J.V.H.,
    H.S.); Janssen Research and Development, Beerse (D.H., C.T., F.S.), Janssen Clinical
    Pharmacology Unit, Merksem (W.V.D.), the Center for Vaccinology, Ghent University,
    Gent (I.L.-R.), SGS Life Sciences (P.-J.B.) and the Center for the Evaluation
    of Vaccination, University of Antwerp (P.V.D.), Antwerp, and the Center for Clinical
    Pharmacology, University Hospitals Leuven, Leuven (J. de Hoon) - all in Belgium;
    Optimal Research, Melbourne, FL (M.K.); the Alliance for Multispecialty Research,
    Knoxville, TN (W.S.); the Center for Virology and Vaccine Research, Beth Israel
    Deaconess Medical Center, Boston (K.E.S., D.H.B.); and the Vaccine and Infectious
    Disease Division, Fred Hutchinson Cancer Research Center, Seattle (S.C.D.R., K.W.C.,
    M.J.M.).
- author_id: https://openalex.org/A5054247332
  display_name: Dan H. Barouch
  orcid: https://orcid.org/0000-0001-5127-4659
  author_position: middle
  institutions:
  - id: https://openalex.org/I1316535847
    display_name: Beth Israel Deaconess Medical Center
    ror: https://ror.org/04drvxt59
    country_code: US
    type: healthcare
  - id: https://openalex.org/I137982388
    display_name: Janssen (Belgium)
    ror: https://ror.org/04yzcpd71
    country_code: BE
    type: company
  - id: https://openalex.org/I4210154236
    display_name: Janssen (Netherlands)
    ror: https://ror.org/04cxegr21
    country_code: NL
    type: company
  is_corresponding: false
  raw_affiliation_strings:
  - From Janssen Vaccines and Prevention, Leiden, the Netherlands (J. Sadoff, M.L.G.,
    G. Shukarev, A.M.G., J. Stoop, S.T., E.C., G. Scheper, J. Hendriks, M.D., J.V.H.,
    H.S.); Janssen Research and Development, Beerse (D.H., C.T., F.S.), Janssen Clinical
    Pharmacology Unit, Merksem (W.V.D.), the Center for Vaccinology, Ghent University,
    Gent (I.L.-R.), SGS Life Sciences (P.-J.B.) and the Center for the Evaluation
    of Vaccination, University of Antwerp (P.V.D.), Antwerp, and the Center for Clinical
    Pharmacology, University Hospitals Leuven, Leuven (J. de Hoon) - all in Belgium;
    Optimal Research, Melbourne, FL (M.K.); the Alliance for Multispecialty Research,
    Knoxville, TN (W.S.); the Center for Virology and Vaccine Research, Beth Israel
    Deaconess Medical Center, Boston (K.E.S., D.H.B.); and the Vaccine and Infectious
    Disease Division, Fred Hutchinson Cancer Research Center, Seattle (S.C.D.R., K.W.C.,
    M.J.M.).
- author_id: https://openalex.org/A5021703028
  display_name: Jenny Hendriks
  orcid: https://orcid.org/0009-0008-8191-6200
  author_position: middle
  institutions:
  - id: https://openalex.org/I1316535847
    display_name: Beth Israel Deaconess Medical Center
    ror: https://ror.org/04drvxt59
    country_code: US
    type: healthcare
  - id: https://openalex.org/I137982388
    display_name: Janssen (Belgium)
    ror: https://ror.org/04yzcpd71
    country_code: BE
    type: company
  - id: https://openalex.org/I4210154236
    display_name: Janssen (Netherlands)
    ror: https://ror.org/04cxegr21
    country_code: NL
    type: company
  is_corresponding: false
  raw_affiliation_strings:
  - From Janssen Vaccines and Prevention, Leiden, the Netherlands (J. Sadoff, M.L.G.,
    G. Shukarev, A.M.G., J. Stoop, S.T., E.C., G. Scheper, J. Hendriks, M.D., J.V.H.,
    H.S.); Janssen Research and Development, Beerse (D.H., C.T., F.S.), Janssen Clinical
    Pharmacology Unit, Merksem (W.V.D.), the Center for Vaccinology, Ghent University,
    Gent (I.L.-R.), SGS Life Sciences (P.-J.B.) and the Center for the Evaluation
    of Vaccination, University of Antwerp (P.V.D.), Antwerp, and the Center for Clinical
    Pharmacology, University Hospitals Leuven, Leuven (J. de Hoon) - all in Belgium;
    Optimal Research, Melbourne, FL (M.K.); the Alliance for Multispecialty Research,
    Knoxville, TN (W.S.); the Center for Virology and Vaccine Research, Beth Israel
    Deaconess Medical Center, Boston (K.E.S., D.H.B.); and the Vaccine and Infectious
    Disease Division, Fred Hutchinson Cancer Research Center, Seattle (S.C.D.R., K.W.C.,
    M.J.M.).
- author_id: https://openalex.org/A5051707431
  display_name: Frank Struyf
  orcid: https://orcid.org/0000-0001-9988-0260
  author_position: middle
  institutions:
  - id: https://openalex.org/I1316535847
    display_name: Beth Israel Deaconess Medical Center
    ror: https://ror.org/04drvxt59
    country_code: US
    type: healthcare
  - id: https://openalex.org/I137982388
    display_name: Janssen (Belgium)
    ror: https://ror.org/04yzcpd71
    country_code: BE
    type: company
  - id: https://openalex.org/I4210154236
    display_name: Janssen (Netherlands)
    ror: https://ror.org/04cxegr21
    country_code: NL
    type: company
  is_corresponding: false
  raw_affiliation_strings:
  - From Janssen Vaccines and Prevention, Leiden, the Netherlands (J. Sadoff, M.L.G.,
    G. Shukarev, A.M.G., J. Stoop, S.T., E.C., G. Scheper, J. Hendriks, M.D., J.V.H.,
    H.S.); Janssen Research and Development, Beerse (D.H., C.T., F.S.), Janssen Clinical
    Pharmacology Unit, Merksem (W.V.D.), the Center for Vaccinology, Ghent University,
    Gent (I.L.-R.), SGS Life Sciences (P.-J.B.) and the Center for the Evaluation
    of Vaccination, University of Antwerp (P.V.D.), Antwerp, and the Center for Clinical
    Pharmacology, University Hospitals Leuven, Leuven (J. de Hoon) - all in Belgium;
    Optimal Research, Melbourne, FL (M.K.); the Alliance for Multispecialty Research,
    Knoxville, TN (W.S.); the Center for Virology and Vaccine Research, Beth Israel
    Deaconess Medical Center, Boston (K.E.S., D.H.B.); and the Vaccine and Infectious
    Disease Division, Fred Hutchinson Cancer Research Center, Seattle (S.C.D.R., K.W.C.,
    M.J.M.).
- author_id: https://openalex.org/A5043150960
  display_name: Macaya Douoguih
  orcid: https://orcid.org/0000-0002-2707-5729
  author_position: middle
  institutions:
  - id: https://openalex.org/I1316535847
    display_name: Beth Israel Deaconess Medical Center
    ror: https://ror.org/04drvxt59
    country_code: US
    type: healthcare
  - id: https://openalex.org/I137982388
    display_name: Janssen (Belgium)
    ror: https://ror.org/04yzcpd71
    country_code: BE
    type: company
  - id: https://openalex.org/I4210154236
    display_name: Janssen (Netherlands)
    ror: https://ror.org/04cxegr21
    country_code: NL
    type: company
  is_corresponding: false
  raw_affiliation_strings:
  - From Janssen Vaccines and Prevention, Leiden, the Netherlands (J. Sadoff, M.L.G.,
    G. Shukarev, A.M.G., J. Stoop, S.T., E.C., G. Scheper, J. Hendriks, M.D., J.V.H.,
    H.S.); Janssen Research and Development, Beerse (D.H., C.T., F.S.), Janssen Clinical
    Pharmacology Unit, Merksem (W.V.D.), the Center for Vaccinology, Ghent University,
    Gent (I.L.-R.), SGS Life Sciences (P.-J.B.) and the Center for the Evaluation
    of Vaccination, University of Antwerp (P.V.D.), Antwerp, and the Center for Clinical
    Pharmacology, University Hospitals Leuven, Leuven (J. de Hoon) - all in Belgium;
    Optimal Research, Melbourne, FL (M.K.); the Alliance for Multispecialty Research,
    Knoxville, TN (W.S.); the Center for Virology and Vaccine Research, Beth Israel
    Deaconess Medical Center, Boston (K.E.S., D.H.B.); and the Vaccine and Infectious
    Disease Division, Fred Hutchinson Cancer Research Center, Seattle (S.C.D.R., K.W.C.,
    M.J.M.).
- author_id: https://openalex.org/A5113602833
  display_name: Johan Van Hoof
  orcid: null
  author_position: middle
  institutions:
  - id: https://openalex.org/I1316535847
    display_name: Beth Israel Deaconess Medical Center
    ror: https://ror.org/04drvxt59
    country_code: US
    type: healthcare
  - id: https://openalex.org/I137982388
    display_name: Janssen (Belgium)
    ror: https://ror.org/04yzcpd71
    country_code: BE
    type: company
  - id: https://openalex.org/I4210154236
    display_name: Janssen (Netherlands)
    ror: https://ror.org/04cxegr21
    country_code: NL
    type: company
  is_corresponding: false
  raw_affiliation_strings:
  - From Janssen Vaccines and Prevention, Leiden, the Netherlands (J. Sadoff, M.L.G.,
    G. Shukarev, A.M.G., J. Stoop, S.T., E.C., G. Scheper, J. Hendriks, M.D., J.V.H.,
    H.S.); Janssen Research and Development, Beerse (D.H., C.T., F.S.), Janssen Clinical
    Pharmacology Unit, Merksem (W.V.D.), the Center for Vaccinology, Ghent University,
    Gent (I.L.-R.), SGS Life Sciences (P.-J.B.) and the Center for the Evaluation
    of Vaccination, University of Antwerp (P.V.D.), Antwerp, and the Center for Clinical
    Pharmacology, University Hospitals Leuven, Leuven (J. de Hoon) - all in Belgium;
    Optimal Research, Melbourne, FL (M.K.); the Alliance for Multispecialty Research,
    Knoxville, TN (W.S.); the Center for Virology and Vaccine Research, Beth Israel
    Deaconess Medical Center, Boston (K.E.S., D.H.B.); and the Vaccine and Infectious
    Disease Division, Fred Hutchinson Cancer Research Center, Seattle (S.C.D.R., K.W.C.,
    M.J.M.).
- author_id: https://openalex.org/A5014967648
  display_name: Hanneke Schuitemaker
  orcid: https://orcid.org/0000-0001-8563-2266
  author_position: last
  institutions:
  - id: https://openalex.org/I1316535847
    display_name: Beth Israel Deaconess Medical Center
    ror: https://ror.org/04drvxt59
    country_code: US
    type: healthcare
  - id: https://openalex.org/I137982388
    display_name: Janssen (Belgium)
    ror: https://ror.org/04yzcpd71
    country_code: BE
    type: company
  - id: https://openalex.org/I4210154236
    display_name: Janssen (Netherlands)
    ror: https://ror.org/04cxegr21
    country_code: NL
    type: company
  is_corresponding: false
  raw_affiliation_strings:
  - From Janssen Vaccines and Prevention, Leiden, the Netherlands (J. Sadoff, M.L.G.,
    G. Shukarev, A.M.G., J. Stoop, S.T., E.C., G. Scheper, J. Hendriks, M.D., J.V.H.,
    H.S.); Janssen Research and Development, Beerse (D.H., C.T., F.S.), Janssen Clinical
    Pharmacology Unit, Merksem (W.V.D.), the Center for Vaccinology, Ghent University,
    Gent (I.L.-R.), SGS Life Sciences (P.-J.B.) and the Center for the Evaluation
    of Vaccination, University of Antwerp (P.V.D.), Antwerp, and the Center for Clinical
    Pharmacology, University Hospitals Leuven, Leuven (J. de Hoon) - all in Belgium;
    Optimal Research, Melbourne, FL (M.K.); the Alliance for Multispecialty Research,
    Knoxville, TN (W.S.); the Center for Virology and Vaccine Research, Beth Israel
    Deaconess Medical Center, Boston (K.E.S., D.H.B.); and the Vaccine and Infectious
    Disease Division, Fred Hutchinson Cancer Research Center, Seattle (S.C.D.R., K.W.C.,
    M.J.M.).
referenced_works:
- https://openalex.org/W2063074246
- https://openalex.org/W2102619382
- https://openalex.org/W2151847720
- https://openalex.org/W2825912598
- https://openalex.org/W2917849476
- https://openalex.org/W3001897055
- https://openalex.org/W3016999238
- https://openalex.org/W3042383115
- https://openalex.org/W3042833857
- https://openalex.org/W3043722389
- https://openalex.org/W3045526555
- https://openalex.org/W3045734160
- https://openalex.org/W3048620154
- https://openalex.org/W3081741393
- https://openalex.org/W3090889278
- https://openalex.org/W3091443388
- https://openalex.org/W3119536390
primary_topic: SARS-CoV-2 and COVID-19 Research
open_access: true
